These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 9588545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
    Abe T, Lüdecke DK.
    Eur J Endocrinol; 2001 Aug; 145(2):137-45. PubMed ID: 11454508
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas.
    Kurosaki M, Luedecke DK, Abe T.
    Endocr J; 2003 Oct; 50(5):635-42. PubMed ID: 14614221
    [Abstract] [Full Text] [Related]

  • 4. Octreotide as primary therapy for acromegaly.
    Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].
    Jaquet P, Cortet-Rudelli Ch, Sassolas G, Morange-Ramos I, Chanson P, Brue T, Andrieu JM, Beckers A, Bertherat J, Borson-Chazot F, Brassier G, Caron P, Cogne M, Cottier JP, Delemer B, Dufour H, Enjalbert A, Figarella-Branger D, Gaillard R, Gueydan M, Jan M, Kuhn JM, Raingeard I, Regis J, Roger P, Rohmer V, Sadoul JL, Saveanu A, Tabarin A, Travers N, Trouillas J, French Acromegly Registry.
    Ann Endocrinol (Paris); 2003 Dec; 64(6):434-41. PubMed ID: 15067248
    [Abstract] [Full Text] [Related]

  • 6. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.
    Shen M, Shou X, Wang Y, Zhang Z, Wu J, Mao Y, Li S, Zhao Y.
    Endocr J; 2010 Dec; 57(12):1035-44. PubMed ID: 21099129
    [Abstract] [Full Text] [Related]

  • 7. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R.
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [Abstract] [Full Text] [Related]

  • 8. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly.
    Abe T, Lüdecke DK.
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):27-35. PubMed ID: 10341853
    [Abstract] [Full Text] [Related]

  • 9. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [Abstract] [Full Text] [Related]

  • 10. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU, Wardlaw SL, Post KD.
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [Abstract] [Full Text] [Related]

  • 11. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.
    Nomikos P, Buchfelder M, Fahlbusch R.
    Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854
    [Abstract] [Full Text] [Related]

  • 12. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D, Hlavica M, Schmid C, Bernays RL.
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [Abstract] [Full Text] [Related]

  • 13. Pituitary surgery in elderly patients with acromegaly.
    Puchner MJ, Knappe UJ, Lüdecke DK.
    Neurosurgery; 1995 Apr; 36(4):677-83; discussion 683-4. PubMed ID: 7596496
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 15. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.
    Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A.
    Eur J Endocrinol; 2005 Jan; 152(1):61-6. PubMed ID: 15762188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U, Quabbe HJ.
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.
    Van Rompaey K, Unuane D, Moens M, Duerinck J, Poppe K, Velkeniers B, D'Haens J.
    Acta Neurol Belg; 2013 Mar; 113(1):49-54. PubMed ID: 22975835
    [Abstract] [Full Text] [Related]

  • 20. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P, Laws ER, Elliott E.
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.